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0929-6441/ª 2015, Elsevier Taiwan LLUltrasound (US) has been an important tool for evaluating and imaging renal pathology in
children. Development of US contrast agents and dedicated software for the detection of
microbubbles has given this radiological investigation a new dimension, especially in children
with renal impairment. Application of contrast-enhanced US (CEUS) brings US into the domain
historically occupied by computed tomography and magnetic resonance imaging. We retro-
spectively studied nine children who had undergone CEUS (age range 3e16 years). This picto-
rial essay draws on our experience and illustrates the safety and accurate depiction of
enhancement pattern of focal renal lesions.
ª 2015, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
Open access under CC BY-NC-ND license.Introduction
Conventional ultrasound (US) has been the mainstay of the
imaging renal system and abdominal organs in clinical
practice, especially in the pediatric age group. With its
advantages of being a nonradiating modality and real-time
imaging, US has become essential in radiological evaluation
in children. The advent of microbubble contrast-enhanced
US (CEUS) has added a new dimension to this essential roledeclare that they have no
ur, Department of Diagnostic
, 5 Lower Kent Ridge Road,
hs.edu.sg (J. Kapur).
.04.001
C and the Chinese Taipei Societyand has the potential of offering insights to enhancing
patterns of organs and masses similar to, if not better than,
conventional computed tomography (CT) and magnetic
resonance imaging (MRI) [1]. We provide an overview of the
use of CEUS for assessment of renal diseases in children in
our hospital.
As US contrast agents consist of microbubbles, and thus
are blood pool agents, implying that they do not leave the
blood vessels and are not subjected to normal renal filtra-
tion nor excretion, they essentially behave like vascular
tracers.
The risk of water-soluble, contrast-induced nephrotoxi-
city and nephrogenic systemic fibrosis with gadolinium in
patients with renal compromise (estimated glomerular
filtration rate < 30mmol/L) has essentially limited the role
of contrast-enhanced CT and MRI in such patients. A
conventional US kidney is often suboptimal in assessment ofof Ultrasound in Medicine. Open access under CC BY-NC-ND license.
Contrast-enhanced Renal Ultrasound in Children 87renal lesion characteristics [2]. Therefore, US contrast
agents, with their relative safety and low incidence of side
effects, offer a unique perspective to renal imaging. They
are not nephrotoxic or cardiotoxic and are excreted in the
lungs, and thus, their use does not require renal function
tests to be performed prior to administration [1,3]. Ricca-
bano and Darge et al and Riccabano and Avni et al all have
found ultrasound contrast agents to be quite safe in use of
children [4,5]. A large retrospective analysis showed that
SonoVue has a good safety profile in abdominal applica-
tions, with an adverse event rate lower than or similar to
that reported for radiological and magnetic resonance
contrast agents [4,5].
SonoVue (sulfur hexafluoride by Bracco, Milan, Italy) is the
only sonographic contrast available in our hospital and was
used in these studies. SonoVue is phospholipid-encapsulated
sulfur hexafluoride microbubbles with an average bubble
diameter of 2.5mm.Fivemilliliters of normal salinewas added
to SonoVue powder to form a suspension, and 1.5 mL of
microbubble suspension was quickly injected via a peripheral
vein (in which a 20 G intravenous cannula had been earlier
inserted), followed by rapid bolus injection of 5 mL normal
saline. We typically injected up to two boluses of well-
dispersed microbubble suspension at an interval of 10e15
minutes. We selected appropriate positions, depending on
different needs to perform coronal, sagittal scans of the kid-
neys. Gray scale US was conducted to observe tumor size,
shape, echo intensity, and demarcation from adjacent tissues
while colorDopplerwas used toexamine the bloodflowwithin
and outside of the tumors. CEUS was performed by fixing a
probe targeted at the mass following selecting a suitable
section.
US equipment used in this study was AS500 (Toshiba
Medical, Tokyo, Japan) and IU22 (Philips Medical, Amster-
dam, The Netherlands), with contrast imaging mode on
these machines.
Renal lesions were compared with their corresponding
normal renal cortex. Lesions with post SonoVue enhance-
ment higher than, lower than, or equaling that of the
cortical echogenicity were defined as hyperenhancing,
hypoenhancing, and isoenhancing, respectively. The
vascular phases were classified into cortical (from 8e15
seconds to 30e35 seconds after injection), cortico-
medullary (from 36e41 seconds to 120 seconds), and late
phase (> 120 seconds to the disappearance of bubbles)
[6e8]. The differences in initial enhancement, the
enhancement extent, and pattern were compared between
the lesion and the peripheral renal cortex. The enhance-
ment extent was classified into hyperenhancement, iso-
enhancement, and hypoenhancement compared with the
surrounding renal parenchyma. In addition, the time in
which the contrast agent entered and exited the mass was
also compared with that of the rest of the normal. “Fast in”
and “fast out” means that inflow and outflow of the
contrast agent into and from the mass is earlier than as
compared to the rest of the renal cortex; “identical in” and
“identical out” mean that the contrast agent enters and
exits the mass and the normal renal cortex at the same
time; and “slow in” and “slow out” mean that inflow and
outflow of the contrast agent are later in the mass than in
the normal cortex. According to CEUS features,comparisons between renal lesions and their surrounding
tissues, the dynamic change patterns of lesions in kidney
and bladder were divided into six types, that is, fast in and
fast out (FIFO), fast in and slow out (FISO), identical in and
fast out (IIFO), identical in and identical out (IIIO), fast in
and identical out (FIIO), and slow in and slow out (SISO) [9].
We present a group of nine children who had undergone
CEUS, age range 3e16 years. Written informed consent was
obtained from the parents before the study and the refer-
ring clinician was present on site at the time of the study.
All these children presented with deranged renal function
(estimated glomerular filtration rate < 30 mmol/L) and had
undergone other limited cross-sectional imaging examina-
tions which were equivocal for underlying disease. As the
use of SonoVue in children is not approved by the Singapore
Health Authority, it was only used as the last viable option
for these children with renal failure, for whom further
contrast imaging with CT or MRI was not possible. The de-
cision to perform CEUS was made as a prelude to possible
surgical intervention and/or biopsy. No episode of allergic
reaction or post procedure complication was encountered
in any of the assessed patients.Renal cysts
Characterization of complex renal cyst remains a common
and sometimes difficult diagnostic dilemma for the refer-
ring urologist and radiologist. These are routinely found
incidentally on radiological investigations. Whether a cyst
enhances or not, is important in differentiating it from
being a malignant lesion, as the chance of neoplasia in-
creases to 40e80% when there is enhancement noted [8].
Although contrast CT/MRI is the gold standard, CEUS has
given evaluation of complex renal cyst a new dimension.
CEUS has the advantage of being able to visualize the thin
fine septa better than CT [2,10]. Fig. 1 shows a simple cyst
in the kidney, with no nodular enhancement of the cyst
wall, and no internal septae or delayed washout. Fig. 2
shows a complex renal cyst, with mild enhancement of
the internal septae. However, no nodular enhancement of
the septa and no washout within the cyst or septae is seen,
rendering it a Bosniack II cyst.Renal angiomyolipoma
Renal angiomyolipoma shows filling in of the contrast agent
starting from the periphery of the echogenic mass and
slowly extend to the center of the lesion with iso- or
hypoenhancement to the rest of the normal renal cortex.
This is most likely due to the presence of malformed blood
vessels with tortuous course and disorganization. These
anatomical features associated with renal angiomyolipoma
result in SISO of the contrast agent, thus the start of the
inflow and outflow of the contrast agent is both later in the
mass than in the renal cortex. Fig. 3 shows a typical renal
angiomyolipoma, where the lesion is seen to be less
enhancing than the adjacent normal renal parenchyma at
all phases, that is, arterial, portal-venous, and delayed
phases.
Fig. 1 Simple renal cyst. Contrast-enhanced ultrasound shows cyst with anechoic cyst without septa, calcification, or solid
components. No enhancement is noted after intravenous contrast agent injection. It is characteristic for a simple Bosniak Type 1
cyst and does not entail further investigation.
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Fig. 2 Complex renal cyst. Noncontrast ultrasound shows a large renal cyst with solid echogenic component within the cyst. Post-
contrast images show no intracystic enhancement and the apparent echogenic solid lesion (white arrow) shows no arterial
enhancement or washout. It was proven on follow-up imaging to be a complicated cyst with some internal hemorrhage.
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CEUS agents do not leave the blood vessels and are not
subjected to renal filtration and thus behave like vascular
tracers. Using CEUS to identify the vessels rather than
Doppler to track the course of the renal artery has been
shown to be accurate and shortens examination time inlarge patients, and of course can be used in patients with
renal impairment [11].
CEUS is a good modality to assess the perfusion pattern
of a kidney. After contrast injection, there is immediate
and prompt enhancement of the kidney, usually seen
within 10 seconds post-injection. The main renal artery,
its bifurcation, the arcuate and segmental arteries are
Fig. 3 Renal angiomyolipoma in an 8-year-old boy, with incidental note of a left kidney mass on bedside ultrasound. Noncontrast
images show a large echogenic exophytic mass, which shows postcontrast enhancement, which is less enhanced than the normal
renal parenchyma on all phases. No significant washout is seen within the lesion.
90 J. Kapur, H. Oscarpromptly enhanced and perfusion can be seen up to the
periphery of the cortex. We present a case in which a 14-
year-old child with known bilateral renal artery stenosis
suddenly became anuria after an attempt of bilateral
renal artery angioplasties (Fig. 4). Noncontrast magnetic
resonance angiography of the abdominal vessels could not
demonstrate the renal arteries (Fig. 5). Hence, a clinical
concern of bilateral renal artery embolization or dissec-
tion was raised, which is a known post-angioplasty
complication. The possibility of auto-transplantation was
being considered in view of deteriorating renal function.
A decision was made to perform bedside CEUS to prove or
disprove if there was viable perfusion within the kidneys.
As our images show (Fig. 6), there was prompt enhance-
ment of the kidneys, with homogeneous corticalenhancement. No perfusion defects were visualized and
the underlying condition was deemed secondary to spasm
of the renal arteries. The renal function recovered over
time with conservative management.Nephronia
A 16-year-old boy noted positive findings on urinemicroscopy
and being treated for urinary tract infection. Post-contrast
US of the echogenic heterogeneous mass in the kidney
showed enhancement similar to the rest of the renal paren-
chyma, with areas of nonenhancement in the center of the
lesion. No washout was noted within this lesion. These fea-
tures are similar to CT imaging features of lobar nephronia.
Fig. 4 Angiographic perfusion. (A) Angiography of the renal artery shows narrowed main renal artery. (B) Multiple collateral
around the main renal artery and distal intrarenal vessels are visualized (red arrows).
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In an appropriate clinical context, CEUS can be used as an
accurate tool in assessment of renal infection and inflam-
matory renal masses. Focal nephronia can often present as
a well-defined mass and causes much confusion and worry
to pediatricians and parents; and CEUS has shown to
improve sensitivity. Regional differences in parenchymal
enhancement are easier to detect than those affecting theFig. 5 Magnetic resonance angiography (MRA-TOF) of the
abdominal aorta. This image shows non-visualization of the
renal arteries and the renal parenchyma, raising suspicion for
an embolic or ischemic insult to both kidneys, post-angioplasty
attempt.entire kidney since the normal parenchyma serves as an
internal reference.
The characteristics on MRI and CT can be nonspecific and
there can be persistent clinical dilemma. We present such a
case in which an 8-year-old boy presented with chills and
fever, which was of short duration and subsequently sub-
sided. On initial US, a well-defined heterogeneously echo-
genic mass was noted in the right kidney. On follow-up,
contrast-enhanced nondynamic MRI of the kidneys revealed
a persistent rounded mass, but the imaging characteristics
were nonspecific and the possibility of a malignant lesion
was considered. Subsequently, the child developed some
renal impairment and follow-up contrast-enhanced axial
imaging was deferred. A clinical decision was made to
perform an open biopsy and possibly tumor resection.
Bedside CEUS was arranged and written consent was ob-
tained from the parents. CEUS showed a heterogeneously
enhancing lesion, with nonenhancing areas in the center of
the lesion. No significant washout was seen and the possi-
bility of focal nephronia and abscess was considered
(Fig. 7). Follow-up US was performed 2 weeks later, after a
course of antibiotics, which showed resolution of the focal
lesion.
Children with pyelonephritis can develop renal abscess
as a complication. As conventional US is poor at depicting,
or confidently identifying these early renal abscesses,
especially when they present at solid lesions in the kidney.
CEUS shows a heterogeneous lesion with central non-
enhancing areas with a thick enhancing rim and a small,
low-attenuation perinephric fluid collection. There is pe-
ripheral enhancement of the lesion with contrast, with no
central enhancement and no washout on delayed images
(Fig. 8).
Pseudotumors
Certain renal anatomic variants, such as persistence of
fetal lobulation, hypertrophied column of Bertin, and
dromedary hump, may present as or have appearances
Fig. 6 Renal perfusion. Post-contrast-enhanced ultrasound shows prompt homogeneous uniform enhancement of both kidneys,
with no perfusion defects or areas of ischemia/necrosis. These images excluded the possibility of a thromboembolic episode within
the kidney and shows that the renal arteries were patent.
92 J. Kapur, H. Oscarsimilar to a solid mass lesion on imaging [9]. There is a
constant dilemma of overcalling or undercalling these le-
sions and conventional US may not suffice to differentiate
or further characterize these lesions. Frequently, these
patients do get subjected to further cross-sectional imaging
such as CT and MRI and published evidence to the role of
CEUS is limited. However, we feel that CEUS can be used to
identify these renal pseudotumors confidently, thus avoid-
ing the more expensive or invasive CT or MRI. Characteris-
tically, all pseudotumors on CEUS would enhance
homogeneously at the same time as the rest of the normal
renal parenchyma and the rate of contrast washout would
also be the same, just like normal renal parenchyma. Fig. 9
depicts an apparent mass on conventional US, which on
post-CEUS shows homogeneous and uniform enhancement,
which is seen to enhance and washout at the same time as
the rest of the normal renal parenchyma.
Malignant masses
Renal cell carcinoma is characterized by numerous thin-
walled blood vessels with rich blood flow physiologically
and intra-tumor necrosis, hemorrhage, and calcification
which are common [12]. Renal cell carcinoma enhances
quickly and intensely after contrast administration due to
the abundant blood flow (Fig. 10). Afterwards, themicrobubbles are washed out rapidly in comparison to the
adjacent normal renal parenchyma [8]. It is deemed that
almost all malignant renal masses show such similar imaging
characteristics on CEUS, with immediate contrast
enhancement and delayed washout (appearing less
enhancing than the adjacent renal parenchyma on delayed
images).
Discussion
Trillaud and colleagues have studied CEUS in comparison
with traditional CT and MRI to classify liver lesions and
found that the specificity and sensitivity to confirmative
histology to be satisfactory [13]. At present, however, few
studies are available on the use of CEUS for renal lesions,
especially in children.
CEUS is useful in children, as this reduces the radiation
burden of CT, and intravenous contrast ultrasound may be
useful in similar indications in adults (such as differential of
focal lesions in parenchymal organs, organ perfusion). CEUS
has proven to be an excellent tool in assessment of renal
perfusion, renal infection (abscess), solid and cystic renal
masses (cysts, angiomyolipomas, and neoplastic lesions),
and pseudomasses.
Conventionally, contrast CT is the gold standard for
assessing renal masses. However, contrast CT has some
Fig. 7 Nephronia. A 16-year-old boy with positive findings on urine microscopy and being treated for urinary tract infection. Post-
contrast-enhanced ultrasound of the echogenic heterogeneous mass in the kidney shows enhancement similar to the rest of the
renal parenchyma, with areas of nonenhancement in the center of the lesion (arrow). No washout was noted within this lesion.
These features are similar to computed tomography imaging features of lobar nephronia.
Contrast-enhanced Renal Ultrasound in Children 93limitations: it cannot be performed in patients with
impaired renal function; and it cannot be used in patients
with previous history of contrast reaction. If a patient is to
be followed up for an indeterminate mass, multiple CT will
be required, which will expose patients to high quantities
of radiation and the associated risks, which is especially
important in the pediatric age group. Although Doppler is a
useful tool to assess vascularity in a renal lesion on con-
ventional US, certain subtle features, such as thin fine
septa or small nodules, may be hard to detect with color
flow Doppler. CEUS has the advantage of being able to
visualize the thin fine septa seen on US and relies onvisualizing the enhancement of vessels with contrast using
harmonic imaging as compared to color flow Doppler. There
is an added advantage of its portability, where it can be
performed even in sick children who are unable to be
transported to the imaging department. There are litera-
ture reports to suggest that CEUS performed better than CT
in the depiction of tumor vascularity in the septa of cystic
renal masses and hence contrast enhancement [13,14].
McCarville et al [15] have shown that CRUS of evaluation of
abdominal tumor is feasible.
The main benefits of CEUS over other investigation mo-
dalities in assessing renal pathology in children is that US
Fig. 8 Renal abscess. A 10-year-old boy being treated for recurrent urinary tract infection. Bedside ultrasound is performed to
look for secondary renal findings, due to persistent high fever (38C), and elevated C-reactive protein markers. Noncontrast images
show a heterogeneous hypoechoic lesion. After contrast-enhanced ultrasound, there is a prompt enhancement of the periphery of
the lesion (arrow), with no central enhancement and no delayed washout. The enhancement timing is similar to the rest of the
renal parenchyma.
94 J. Kapur, H. Oscarcontrast agents are not nephrotoxic and can be used safely
in patients with impaired renal function [8]. Such an
advantage, coupled with lack of ionizing radiation [16] adds
value to assessment of renal diseases. The realcontraindication for the use of CEUS would be a history of
acute cardiovascular disease, right to left shunts, ongoing
myocardial infarction, severe rhythm disorders, and severe
respiratory failure including respiratory distress syndrome.
Fig. 9 Pseudotumor. A 15-year-old girl, with incidental findings of a nonspecific mass on bedside US. Noncontrast-enhanced US
shows an area of apparent altered echogenicity (arrow) in the interpolar region of the kidney, which is suspicious for a possible
mass lesion. Post-contrast-enhanced US shows prompt and homogeneous enhancement in this area, with similar enhancement to
the rest of the kidney, with no abnormal enhancement or washout, thus proving this to be normal renal tissue, likely to be
prominent Column of Bertin. US Z ultrasound.
Contrast-enhanced Renal Ultrasound in Children 95Care should be taken in patients with chronic obstructive
pulmonary disease and pulmonary hypertension, and these
patients should be monitored.
The use of CEUS as an imaging modality does have some
limitations: a relatively short diagnostic window needing
two contrast injections for the same kidney or one injection
for each kidney. Simultaneous assessment of more than onefocal lesion may be difficult and may require multiple in-
jections in the same sitting. In general, US is relatively
harder to interpret in obese patients and bowel gas can
interfere with images. Patient compliance is required as
the mass may not be visible in one particular position.
Contrast agents for CEUS are not yet approved for general
pediatric use. Due to the lack of official approval from the
Fig. 10 Renal cell carcinoma. A 13-year-old boy presented with hematuria for investigation. Following contrast administration,
the lesion shows homogeneous central enhancement within the lesion (double arrows), which appears less enhanced as compared
to the rest of the renal parenchyma. However, it shows washout in the delayed images (double arrows) and appears suspicious for a
malignant lesion. It was histologically proven to be a renal cell carcinoma.
96 J. Kapur, H. OscarHealth Science Authority of Singapore for the use of Sono-
Vue, in our hospital, we have limited the use of CEUS as a
last resort only in those children who have compromised
renal function and other imaging modalities are equivocal
in arriving to a diagnosis.
CEUS is an accurate, relatively cheap, and non-radiation
modality, with accurate depiction of enhancement patterns
of focal renal lesions. It is safe to be used in children withrenal insufficiency and renal failure and appears to have
minimal incidence of contrast allergy. None of the patients
in our cohort had an allergic response to SonoVue. Its ac-
curacy is at least similar, if not more than CT or MRI in the
assessment of focal renal lesions and can be used as a
modality of choice for solitary focal renal lesions in the
presence or absence of renal insufficiency [17,18]. Its role
in the pediatric age group has been less defined and further
Contrast-enhanced Renal Ultrasound in Children 97studies should be performed to validate its use a safe and
viable alternative to CT and MRI imaging for renal diseases.
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